The Green Bay Packers will bring the Packers Vs. Cancer initiative to Pulaski on Friday, Oct. 6, when the Pulaski High School Red Raiders host the Green Bay Southwest High School Trojans.
Packers players Anders Carlson, Keisean Nixon and Daniel Whelan will join fans at the game, which takes place at 7 p.m. at Pulaski High School at 1040 S. St. Augustine St., Pulaski, Wis. The players will interact with the crowd and throw autographed foam footballs into the stands at the end of the first quarter.
The event will also feature t-shirts and raffle tickets for sale for $10 and $1, respectively. Winners of the raffle will receive autographed Packers items, and 100 percent of the proceeds from the sales will be donated to the Vince Lombardi Cancer Foundation.
Football fans and community members are invited to attend the game, but for those who can't be in Pulaski in person, the game will be broadcast live on WACY – TV32.
Packers Vs. Cancer, presented by Bellin Health, is aimed at raising awareness of all cancers, increasing cancer screenings and raising funds to battle the disease, and runs throughout the month of October. The initiative was highlighted during last Thursday's Packers-Lions game, presented by Bellin Health, and recognized cancer survivors and those battling the disease.
Packers Vs. Cancer also features a variety of fundraising opportunities for shoppers at the Packers Pro Shop. Fans can purchase a new Packers Vs. Cancer hat, with $5 from each hat sale going directly to the Vince Lombardi Cancer Foundation. The green New Era winter knit hat features the Packers logo on the front and the Packers Vs. Cancer logo on the side. Shoppers can also help raise funds for the Vince Lombardi Cancer Foundation by adding a $1 or more donation to any purchase, starting now through October 16. Those who donate will help contribute to the Vince Lombardi Cancer Foundation's ongoing cancer research programs.
Named for the legendary Packers coach, the Vince Lombardi Cancer Foundation is dedicated to winning the battle against cancer by funding advancements in cancer research and compassionate care.
